BIO Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . BIO Key International
BKYI Stock  USD 0.61  0.04  6.15%   
BIO Key's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BIO Key's valuation are provided below:
Gross Profit
5 M
Profit Margin
(0.67)
Market Capitalization
6.6 M
Enterprise Value Revenue
1.0406
Revenue
6.3 M
We have found one hundred twenty available fundamental signals for BIO Key International, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of BIO Key International prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The BIO Key's current Market Cap is estimated to increase to about 7.7 M. The BIO Key's current Enterprise Value is estimated to increase to about 10.8 M

BIO Key Total Revenue

5.08 Million

Check BIO Key financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BIO Key's main balance sheet or income statement drivers, such as Depreciation And Amortization of 597.6 K, Interest Expense of 256.3 K or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 1.04, Dividend Yield of 0.0507 or PTB Ratio of 1.66. BIO financial statements analysis is a perfect complement when working with BIO Key Valuation or Volatility modules.
  
Build AI portfolio with BIO Stock
Check out the analysis of BIO Key Correlation against competitors.

BIO Key Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets10 M9.9 M9.4 M
Slightly volatile
Short and Long Term Debt Total2.2 M1.6 M1.8 M
Pretty Stable
Other Current Liabilities919.5 K1.1 M740.1 K
Slightly volatile
Total Current Liabilities3.1 M4.1 M2.6 M
Slightly volatile
Property Plant And Equipment Net226.8 K245.6 K212.4 K
Slightly volatile
Accounts Payable704.2 K940.9 K693.6 K
Slightly volatile
Cash478.1 K503.2 K2.3 M
Pretty Stable
Non Current Assets Total5.1 M7.7 M4.1 M
Slightly volatile
Non Currrent Assets Other456 K480 K4 M
Slightly volatile
Cash And Short Term Investments478.1 K503.2 K2.3 M
Pretty Stable
Common Stock Total Equity6697044.4 K
Slightly volatile
Common Stock Shares Outstanding4.7 M4.4 M898.3 K
Slightly volatile
Liabilities And Stockholders Equity10 M9.9 M9.4 M
Slightly volatile
Inventory631.7 K435.1 K878 K
Slightly volatile
Other Current Assets563.6 K320.4 K808.4 K
Pretty Stable
Other Stockholder Equity160.6 M153 M91.8 M
Slightly volatile
Total Liabilities4.7 M4.4 M2.8 M
Slightly volatile
Property Plant And Equipment Gross1.7 M1.6 M515.3 K
Slightly volatile
Total Current Assets2.1 M2.2 M5.1 M
Pretty Stable
Short Term Debt991.5 K1.5 M736.6 K
Slightly volatile
Common Stock3183354.7 K
Slightly volatile
Property Plant Equipment240.4 K371.8 K231.5 K
Slightly volatile
Current Deferred Revenue980.3 K695.9 K507.4 K
Slightly volatile
Other Liabilities57.5 K60.6 K151.3 K
Slightly volatile
Intangible Assets938.5 K987.9 K3.5 M
Slightly volatile
Capital Surpluse88.3 M137.8 M89.1 M
Slightly volatile
Non Current Liabilities Other345.7 K355.5 K327.2 K
Slightly volatile
Capital Stock6633351.1 K
Slightly volatile
Capital Lease Obligations63 K66.3 K400.7 K
Slightly volatile
Short and Long Term Debt990.2 K1.5 M1.8 M
Slightly volatile

BIO Key Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization597.6 K429.8 K484.7 K
Slightly volatile
Interest Expense256.3 K269.8 K428.6 K
Pretty Stable
Selling General Administrative5.2 M8.2 M5 M
Slightly volatile
Total Revenue5.1 M8 M4.5 M
Slightly volatile
Other Operating Expenses9.6 M12.6 M9.4 M
Slightly volatile
Research Development2.3 M2.9 M1.8 M
Slightly volatile
Cost Of Revenue1.8 M1.5 M2 M
Slightly volatile
Total Operating Expenses7.9 M11.1 M7.4 M
Slightly volatile
Extraordinary Items240 K270 K294.7 K
Slightly volatile
Interest Income94.0599.059.3 K
Slightly volatile
Selling And Marketing Expenses1.8 M2 M2.2 M
Slightly volatile
Preferred Stock And Other Adjustments628.7 K692.2 K770.1 K
Slightly volatile
Reconciled Depreciation671.1 K429.8 K1.1 M
Slightly volatile

BIO Key Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow558.7 K588.1 K2.3 M
Pretty Stable
Depreciation615.5 K429.8 K478.5 K
Slightly volatile
End Period Cash Flow478.1 K503.2 K2.3 M
Pretty Stable
Stock Based Compensation449.9 K279.7 K435.7 K
Pretty Stable
Change To Netincome791.8 K833.4 K1 M
Pretty Stable

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.041.136.7827
Slightly volatile
Dividend Yield0.05070.04830.0458
Slightly volatile
Average Payables587.4 K960.4 K719.4 K
Slightly volatile
Stock Based Compensation To Revenue0.030.03160.1018
Very volatile
Capex To Depreciation0.02980.03140.6156
Slightly volatile
EV To Sales1.251.3236.7734
Slightly volatile
Inventory Turnover3.723.9222.9539
Slightly volatile
Days Of Inventory On Hand242123327
Pretty Stable
Payables Turnover2.071.422.9978
Pretty Stable
Sales General And Administrative To Revenue0.671.190.9337
Slightly volatile
Average Inventory352.3 K370.8 K1.2 M
Slightly volatile
Research And Ddevelopement To Revenue0.40.421.1064
Slightly volatile
Capex To Revenue0.00210.00220.0959
Slightly volatile
Cash Per Share0.120.1321.1794
Slightly volatile
Days Payables Outstanding253266498
Slightly volatile
Income Quality0.980.612.3198
Slightly volatile
Intangibles To Total Assets0.140.150.2575
Slightly volatile
Current Ratio0.350.372.3594
Very volatile
Capex Per Share0.00370.00392.1194
Slightly volatile
Average Receivables1.2 M942 K1.5 M
Slightly volatile
Revenue Per Share1.962.0659.1697
Slightly volatile
Interest Debt Per Share0.590.6221.881
Slightly volatile
Debt To Assets0.230.240.6142
Slightly volatile
Graham Number651593537
Very volatile
Operating Cycle163171406
Pretty Stable
Days Of Payables Outstanding253266498
Slightly volatile
Ebt Per Ebit1.020.9777.709
Slightly volatile
Quick Ratio0.280.32.0206
Very volatile
Net Income Per E B T0.530.90.8993
Pretty Stable
Cash Ratio0.08220.08651.1194
Very volatile
Days Of Inventory Outstanding242123327
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.121.161.0445
Very volatile
Fixed Asset Turnover32.1729.237.6048
Slightly volatile
Debt Ratio0.230.240.6142
Slightly volatile
Price Sales Ratio1.041.136.7827
Slightly volatile
Asset Turnover0.630.720.9844
Slightly volatile

BIO Key Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap7.7 M6 M11.4 M
Pretty Stable
Enterprise Value10.8 M9.1 M8.4 M
Slightly volatile

BIO Fundamental Market Drivers

BIO Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About BIO Key Financial Statements

Investors use fundamental indicators, such as BIO Key's revenue or net income, to determine how well the company is positioned to perform in the future. Although BIO Key's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue695.9 K980.3 K
Total Revenue8 M5.1 M
Cost Of Revenue1.5 M1.8 M
Stock Based Compensation To Revenue 0.03  0.03 
Sales General And Administrative To Revenue 1.19  0.67 
Research And Ddevelopement To Revenue 0.42  0.40 
Revenue Per Share 2.06  1.96 
Ebit Per Revenue(0.52)(0.55)

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:
How To Invest In BIO
Details
Is BIO Stock a good investment?
Details
What is BIO Key's Net Worth?
Details
Largest Systems Software Companies
View
Largest Security & Protection Services Companies
View
Check out the analysis of BIO Key Correlation against competitors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is there potential for Systems Software market expansion? Will BIO introduce new products? Factors like these will boost the valuation of BIO Key. Projected growth potential of BIO fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.85)
Revenue Per Share
1.243
Quarterly Revenue Growth
(0.28)
Return On Assets
(0.29)
Return On Equity
(1.38)
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between BIO Key's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BIO Key should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, BIO Key's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY